This technical guide outlines the chemical profile, preclinical literature, handling protocols, and quality verification criteria for investigators conducting a PT 141 Bremelanotide peptide online aankoop (online purchase for laboratory research). PX1 Research provides analytical-grade research compounds backed by lot-specific COAs, HPLC purity assays, and mass spectrometry validation for qualified academic and institutional facilities.
This technical guide outlines the chemical profile, preclinical literature, handling protocols, and quality verification criteria for investigators conducting a PT 141 Bremelanotide peptide online aankoop (online purchase for laboratory research). PX1 Research provides analytical-grade research compounds backed by lot-specific COAs, HPLC purity assays, and mass spectrometry validation for qualified academic and institutional facilities.
Investigators conducting a PT 141 bremelanotide peptide online aankoop (online purchase for scientific research) require analytical-grade material backed by documented purity verification. PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist evaluated in preclinical studies for central nervous system signaling pathways related to neuroendocrine response and sexual-health pathways.
When sourcing PT-141 Bremelanotide online, laboratory procurement specialists must ensure the compound is verified via Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS), maintaining a purity threshold of ≥98.0%. PX1 Research provides USA-manufactured peptides shipped from dual California and Arizona facilities, with every batch subjected to independent ISO 17025 laboratory testing and endotoxin quantification.
PT-141, chemically designated as Bremelanotide, is a synthetic derivative of alpha-melanocyte-stimulating hormone (α-MSH). Structurally, it is a cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH and a molecular formula of C50H68N14O10, possessing a molecular weight of approximately 1025.16 g/mol. The cyclic lactam bridge between the aspartic acid and lysine residues imparts significant conformational stability compared to linear peptide analogs.
Unlike first-generation MSH analogs, PT-141 features a specific active pharmacophore sequence that targets central melanocortin receptors without relying on direct nitric oxide donation or peripheral vascular mechanisms. Laboratory investigators studying melanocortin receptor agonists utilize this stabilized structure to evaluate downstream receptor binding kinetics and intracellular cyclic adenosine monophosphate (cAMP) accumulation in cell-based assays.
Preclinical studies indicate that PT-141 acts primarily as a high-affinity agonist at melanocortin sub-types 3 and 4 receptors (MC3R and MC4R) located within the central nervous system. Activation of MC4R in the paraventricular nucleus (PVN) and medial preoptic area (mPOA) of the hypothalamus initiates downstream neuronal signaling networks involved in behavioral motivation, neuroendocrine output, and autonomic regulation.
In animal models, administration of Bremelanotide demonstrated central activation of dopamine pathway neurons in the nucleus accumbens without inducing direct peripheral vasodilation typical of phosphodiesterase-5 (PDE-5) inhibitors. In vitro binding assays confirm that Bremelanotide exhibits minimal affinity for the MC1R receptor relative to its parent compound, reducing its melanogenic potential while sharpening its utility for neurobehavioral research. Scientists referencing the broader literature via our research hub analyze these pathways to map non-vascular regulatory mechanisms governing appetitive and physiological responses.
To properly contextualize PT-141 within experimental protocols, researchers frequently compare its receptor binding profiles against related compounds in the melanocortin peptide family. The primary reference molecules evaluated alongside PT-141 include Melanotan II and Melanotan 1.
While Melanotan II (MT-II) acts as a non-selective agonist across MC1R, MC3R, MC4R, and MC5R, PT-141 is a metabolite derivative designed to offer greater selectivity for MC3R and MC4R pathways while minimizing MC1R-mediated skin pigmentation pathways. Melanotan 1 (Afamelanotide), conversely, acts predominantly on peripheral MC1R receptors in melanocytes. Comparing these target affinities allows research laboratories to select the precise peptide ligand required for their specific receptor binding or cell signaling models. Explore our full catalog of all research peptides to compare specifications.
Proper handling of lyophilized PT-141 is critical to preserve peptide integrity and prevent chemical degradation through deamidation or oxidation. Lyophilized vials should be stored upon receipt in a laboratory freezer at -20°C or -80°C for long-term stability. Prior to reconstitution, vials must be allowed to equilibrate to room temperature to prevent condensation within the container.
Reconstitution should be performed using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile endotoxin-free water depending on the requirements of the downstream in vitro or cell culture assay. The diluent should be introduced slowly along the glass wall of the vial, followed by gentle swirling. Never vortex or vigorously shake peptide solutions, as mechanical shear stress can disrupt the secondary structure. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and stored at 2°C to 8°C for short-term experimental series.
Executing a verified PT 141 bremelanotide peptide online aankoop requires strict adherence to vendor quality standards. Due to the proliferation of unverified research suppliers, academic and corporate research facilities must mandate comprehensive analytical documentation for every lot number before introducing materials into experimental pipelines.
A rigorous quality assurance protocol requires vendor compliance across three primary analytical domains:
1. Reversed-Phase HPLC (RP-HPLC): Establishes chemical purity, confirming that the target peptide peak accounts for ≥98.0% of the total area under the curve, free of truncation sequences or residual side-chain protectants.
2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass, verifying identity against theoretical values (1025.16 Da) without structural modifications or salt imbalances.
3. Bacterial Endotoxin Assay: Limulus Amebocyte Lysate (LAL) testing ensures endotoxin levels remain below strictly controlled limits (<0.01 EU/mg), preventing confounding inflammatory responses in cell culture models.
PX1 Research enforces these standards through independent ISO 17025 accredited laboratory testing, issuing a lot-specific Certificate of Analysis (COA) with every order.
A legitimate Certificate of Analysis serves as the definitive proof of peptide purity and identity. When reviewing documentation during a procurement cycle, researchers should verify that the batch number on the vial matches the COA header exactly, alongside clear identification of the testing laboratory and date of analysis.
Inspect the RP-HPLC chromatogram for a sharp, clean primary peak with minimal baseline drift or shoulder peaks. The MS spectrum must display clear mass-to-charge (m/z) signals corresponding to the ionized states of Bremelanotide. Vendors offering non-lot-specific template COAs or lacking mass spec verification fail to meet institutional procurement requirements. PX1 Research publishes verifiable COAs for all batches directly accessible through our platform, supporting full audit compliance for institutional accounts and wholesale research accounts.
PX1 Research operates as a trusted USA-based supplier dedicated exclusively to serving laboratory research institutions, university scientific departments, and biotechnology firms. We do not manufacture or distribute products for human consumption, maintaining an absolute focus on scientific-grade research compounds.
Our supply chain advantages include USA-based manufacturing under strict Quality Management Systems (QMS), lot-by-lot HPLC and ESI-MS validation, endotoxin testing, and fast fulfillment from our dual California and Arizona distribution centers. Orders placed Monday through Friday ship same-day, ensuring cold-chain integrity and minimal transit delays for sensitive scientific reagents.
What is the primary mechanism of PT-141 (Bremelanotide) in preclinical models?
Preclinical studies demonstrate that PT-141 acts as a synthetic agonist at melanocortin receptors MC3R and MC4R within the central nervous system, modulating neuroendocrine pathways and behavioral responses without activating direct vascular smooth muscle mechanisms.
What analytical purity level is guaranteed for PT-141 from PX1 Research?
PX1 Research guarantees a minimum chemical purity of ≥98.0% for PT-141, as verified by lot-specific Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS).
How should lyophilized PT-141 powder be stored upon delivery?
Lyophilized PT-141 should be stored at -20°C for standard laboratory storage or -80°C for extended stability. It should be kept desiccated and protected from direct light.
What solvent is recommended for reconstituting PT-141 for in vitro research?
PT-141 is typically reconstituted using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile endotoxin-free water depending on the requirements of the experimental assay.
Does PX1 Research provide lot-specific Certificates of Analysis?
Yes. Every lot of PT-141 shipped by PX1 Research includes a lot-specific Certificate of Analysis generated by an independent, ISO 17025 accredited analytical testing facility detailing HPLC purity, mass spectrometry confirmation, and endotoxin levels.
How does PT-141 differ structurally from Melanotan II?
PT-141 is a hydroxylated carboxylic acid metabolite of Melanotan II. While MT-II retains a C-terminal amide structure and acts non-selectively across MC1R-MC5R, PT-141 exhibits optimized binding selectivity for central MC3R and MC4R receptors.
What are the shipping locations and handling speeds for orders?
PX1 Research dispatches all research compounds from domestic distribution hubs in California and Arizona. Orders placed before daily cutoffs Monday through Friday ship same-day.
Are PT-141 research compounds intended for clinical or human use?
No. All products offered by PX1 Research, including PT-141, are strictly intended for laboratory research, in vitro assays, and preclinical animal models. They are not for human or veterinary medical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.